PPLPHARMA

HealthcareDrug Manufacturers - Specialty & GenericLarge Cap
Piramal Pharma Limited

Piramal Pharma Limited (PPLPHARMA) operates as a healthcare company specializing in specialty and generic drug manufacturing. It offers a portfolio of pharmaceutical products and s...

हिन्दी में

Piramal Pharma Limited (PPLPHARMA) स्वास्थ्य सेवा क्षेत्र में एक कंपनी है जो विशेष और जेनेरिक दवा विनिर्माण में विशेषज्ञता रखती है। यह संयुक्त राज्य अमेरिका, यूरोप, जापान, भारत और ...

₹203.01+1.24%1D
Previous trading day close · Data updates after market close
1W: -1.7%
1M: -7.6%
6M: +42.0%
1Y: +2.3%
47/100
Below AvgResearch Score
Market Cap
₹22.2K Cr
Large Cap
P/E Ratio
-71.63
Negative earnings
P/B Ratio
3.30
Premium
ROE
1.1%
Weak
ROCE
1.2%
Average
Debt / Equity
0.70
Moderate
Div. Yield
N/A
EV/EBITDA
34.49
Expensive
52W Low: ₹132.3Current: ₹203.0152W High: ₹231.93
At 71% of 52-week range
Data as of previous trading day close · Updated after market close
📉 Full Technical Chart (RSI, MACD, ADX)
📊
Loading chart...
── Price── SMA50── SMA200Data: Previous trading day close · Updated after market close
Research Score Breakdown
5-factor fundamental analysis — not a buy/sell signal
Quality
ROE, ROCE, margins, cash flow
44/100
Growth
Revenue, EPS, profit growth
46/100
Valuation
PE, PB, EV/EBITDA vs sector
45/100
Risk
Debt levels, volatility, coverage
53/100
News Sentiment
Recent news sentiment
50/100
Weightage: Quality 30% + Growth 25% + Valuation 20% + Risk 15% + News 10%
Mathematical score — not investment advice
Valuation Ratios
P/E Ratio
-71.63(Negative earnings)
Forward P/E
49.84(Premium)
P/B Ratio
3.30(Premium)
P/S Ratio
2.92(Good)
EV/EBITDA
34.49(Expensive)
Dividend Yield
N/A
5Y CAGR
N/A
Revenue Growth
17.4%(Moderate)
Profitability
ROE
1.1%(Average)
ROCE
1.2%(Average)
ROA
0.6%(Average)
Net Margin
-3.4%(Low)
EBITDA Margin
11.3%
Financial Health
Debt to Equity
0.70(Moderate)
Current Ratio
1.54(Healthy)
Quick Ratio
0.93(Tight)
Interest Coverage
0.48x(Low)
Technical Indicators
Based on previous trading day close
RSI (14)
51(Neutral)
RSI Exp (14)
38(Neutral)
MACD
-2.080(Bearish)
MACD Signal
-0.696
BB Position
33%(Middle)
BB Width
13.68%(Normal)
ADX (14)
20.9(Weak trend)
Williams %R
-59.6(Neutral)
MFI (14)
45(Neutral)
CCI (20)
-76(Neutral)
Stoch %K
40(Neutral)
ATR (14)
6.73(Avg True Range)
OBV (M)
816.0(Positive)
1W OBV Chg
-0.5%(Decreasing)
Rel Volume
0.44x(Low activity)
Volatility
40.3%(High)
Max DD 1Y
-54.6%(High loss)
Alpha (CAPM)
-0.72%(Underperforming)
Return vs Nifty
10.1%(Beating Nifty)
EMA 200
187.3
EMA 50
203.4
SMA 200
174.7
vs SMA 50
-2.7%(Below SMA50)
vs SMA 200
16.2%(Above SMA200)
Volume
22.96L
Avg Vol 3M
52.6L
Shareholding Pattern
Promoter
34.9%
Low stake
FII
30.2%
Strong foreign interest
DII / MF
15.6%
Strong MF interest
Share PPLPHARMA
Share this stock analysis with your network
𝕏 Share on XWhatsAppLinkedIn
⚠️ Research Score is a mathematical fundamental score — not investment advice. Data updates after market close. Please consult a SEBI-registered advisor before investing.